Teleflex announces favorable results for UroLift™ in treating BPH, showing higher patient satisfaction and better early recovery compared to Rezūm. Teleflex Incorporated announced new results from the ...

Physician brings non-surgical outpatient prostate procedure to McLaren Northern Michigan, providing quicker recovery times. Featured in the 2021 issue of MyNorth Medical Insider. When Bryan Shumaker, ...

Two Head-to-Head Randomized Trials Highlight Superior Early Patient Experience with the UroLift™ System for BPH 1-2 First-Ever Analysis Utilizing the American Urological Association Quality Registry ...

WAYNE, Pa., March 09, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced that, globally, 250,000 patients have been treated with the UroLift® System, a proven, minimally ...

“The UroLift ® System is a proven treatment method in my practice for patients seeking relief from an enlarged prostate,” said Steven Gange, M.D., F.A.C.S., of Summit Urology Group and Associate ...

WAYNE, Pa., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that new data published in the peer-reviewed journal, European Urology Focus, found that men treated ...

DEAR DR. ROACH: I’m 79, and for several years, I have been taking finasteride and tamsulosin for benign prostatic hyperplasia. (In the past, I underwent a TURP procedure, which I will never go through ...

Over the past decade, Teleflex has transformed from a diverse industrial, commercial, and healthcare company to one focused on single-use medical devices using the dual levers of acquisitions and ...